PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9825565-0	1998	Methimazole treatment in Graves" disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.	Methimazole	0-11	CD5 molecule	Homo sapiens	55-58	
8958783-10	1996	These results show that, in vivo, GD patients treated with methimazole exhibited an abnormal but rather stable pattern of B cell distribution, similar to that present in hyperthyroid untreated GD patients, except for the CD5+ and CD5- B cell populations.	Methimazole	59-70	CD5 molecule	Homo sapiens	221-224	
8958783-10	1996	These results show that, in vivo, GD patients treated with methimazole exhibited an abnormal but rather stable pattern of B cell distribution, similar to that present in hyperthyroid untreated GD patients, except for the CD5+ and CD5- B cell populations.	Methimazole	59-70	CD5 molecule	Homo sapiens	230-233	
8811329-2	1996	The combination of flow cytometry and 3-color immunofluorescence revealed a remarkable increase in the absolute numbers of CD5+ B cells in hyperthyroid-untreated GD patients (218 +/- 137 x 10(6)/l vs. 66 +/- 69 x 10(6)/l in healthy subjects, p < 0.01) that gradually fell to normal values once hyperthyroidism had been controlled by methimazole.	Methimazole	336-347	CD5 molecule	Homo sapiens	123-126